Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pediatric Nephrology
Published in: Pediatric Nephrology 1/2013

01-01-2013 | Original Article

Impact of sepsis on the urinary level of interleukin-18 and cystatin C in critically ill neonates

Authors: Yanhong Li, Xiaozhong Li, Xiaofei Zhou, Jie Yan, Xueping Zhu, Jian Pan, Meifang Jin, Xueming Zhu, Xing Feng, Zhihui Xiao

Published in: Pediatric Nephrology | Issue 1/2013

Login to get access

Abstract

Background

Urinary interleukin-18 (uIL-18) and cystatin C (uCysC) are biomarkers of acute kidney injury (AKI). We hypothesized that in non-AKI neonates, the level of uIL-18 and uCysC would be higher in those with sepsis compared to those without sepsis. The aims of this study were to determine the association between urinary biomarkers and sepsis in non-AKI critically ill neonates, and to evaluate whether uIL-18 and uCysC could serve as predictors of sepsis in this population.

Methods

The study included 111 non-AKI critically ill neonates with acute clinical deterioration suggestive of sepsis: 26 with infection, 57 without infection, and 28 were assigned to the unclassified group. Urinary samples were collected and a full sepsis screen was performed at the time of enrollment.

Results

The level of uIL-18, but not uCysC, was significantly elevated in non-AKI septic neonates. Urinary IL-18 was an independent factor associated with sepsis assessed by multivariate analysis, had odds ratio of 1.73 (95 % CI 1.15 to 2.58, p = 0.008), and achieved the area under the receiver operating characteristic curve of 0.74 for predicting the presence of sepsis in non-AKI critically ill neonates.

Conclusions

Sepsis has an impact on the level of uIL-18, but not on the uCysC in non-AKI neonates, suggesting systemic infection might influence the diagnostic value of uIL-18 to detect AKI in the general population.
Literature
1.
Askenazi DJ, Griffin R, McGwin G, Carlo W, Ambalavanan N (2009) Acute kidney injury is independently associated with mortality in very low birthweight infants: a matched case–control analysis. Pediatr Nephrol 24:991–997PubMedCrossRef
2.
Askenazi DJ, Ambalavanan N, Goldstein SL (2009) Acute kidney injury in critically ill newborns: what do we know? What do we need to learn? Pediatr Nephrol 24:265–274PubMedCrossRef
3.
Askenazi DJ, Montesanti A, Hunley H, Koralkar R, Pawar P, Shuaib F, Liwo A, Devarajan P, Ambalavanan N (2012) Urine biomarkers predict acute kidney injury and mortality in very low birth weight infants. J Pediatr 159(907–912):e901
4.
Li Y, Fu C, Zhou X, Xiao Z, Zhu X, Jin M, Li X, Feng X (2012) Urine interleukin-18 and cystatin C as biomarkers of acute kidney injury in critically ill neonates. Pediatr Nephrol 27:851–860PubMedCrossRef
5.
Askenazi DJ, Koralkar R, Levitan EB, Goldstein SL, Devarajan P, Khandrika S, Mehta RL, Ambalavanan N (2011) Baseline values of candidate urine acute kidney injury biomarkers vary by gestational age in premature infants. Pediatr Res 70:302–306PubMedCrossRef
6.
Nejat M, Pickering JW, Walker RJ, Westhuyzen J, Shaw GM, Frampton CM, Endre ZH (2010) Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit. Crit Care 14:R85PubMedCrossRef
7.
Royakkers AA, Korevaar JC, van Suijlen JD, Hofstra LS, Kuiper MA, Spronk PE, Schultz MJ, Bouman CS (2011) Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy. Intensive Care Med 37:493–501PubMedCrossRef
8.
Parikh CR, Abraham E, Ancukiewicz M, Edelstein CL (2005) Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol 16:3046–3052PubMedCrossRef
9.
Haase M, Bellomo R, Story D, Davenport P, Haase-Fielitz A (2008) Urinary interleukin-18 does not predict acute kidney injury after adult cardiac surgery: a prospective observational cohort study. Crit Care 12:R96PubMedCrossRef
10.
Tschoeke SK, Oberholzer A, Moldawer LL (2006) Interleukin-18: a novel prognostic cytokine in bacteria-induced sepsis. Crit Care Med 34:1225–1233PubMedCrossRef
11.
Washburn KK, Zappitelli M, Arikan AA, Loftis L, Yalavarthy R, Parikh CR, Edelstein CL, Goldstein SL (2008) Urinary interleukin-18 is an acute kidney injury biomarker in critically ill children. Nephrol Dial Transplant 23:566–572PubMedCrossRef
12.
Siew ED, Ikizler TA, Gebretsadik T, Shintani A, Wickersham N, Bossert F, Peterson JF, Parikh CR, May AK, Ware LB (2010) Elevated urinary IL-18 levels at the time of ICU admission predict adverse clinical outcomes. Clin J Am Soc Nephrol 5:1497–1505PubMedCrossRef
13.
Bagshaw SM, Langenberg C, Haase M, Wan L, May CN, Bellomo R (2007) Urinary biomarkers in septic acute kidney injury. Intensive Care Med 33:1285–1296PubMedCrossRef
14.
Inker LA, Okparavero A (2011) Cystatin C as a marker of glomerular filtration rate: prospects and limitations. Curr Opin Nephrol Hypertens 20:631–639PubMedCrossRef
15.
Andersen TB, Eskild-Jensen A, Frokiaer J, Brochner-Mortensen J (2009) Measuring glomerular filtration rate in children; can cystatin C replace established methods? A review. Pediatr Nephrol 24:929–941PubMedCrossRef
16.
17.
Herget-Rosenthal S, van Wijk JA, Brocker-Preuss M, Bokenkamp A (2007) Increased urinary cystatin C reflects structural and functional renal tubular impairment independent of glomerular filtration rate. Clin Biochem 40:946–951PubMedCrossRef
18.
Conti M, Moutereau S, Zater M, Lallali K, Durrbach A, Manivet P, Eschwege P, Loric S (2006) Urinary cystatin C as a specific marker of tubular dysfunction. Clin Chem Lab Med 44:288–291PubMedCrossRef
19.
Hellerstein S, Berenbom M, Erwin P, Wilson N, DiMaggio S (2004) The ratio of urinary cystatin C to urinary creatinine for detecting decreased GFR. Pediatr Nephrol 19:521–525PubMedCrossRef
20.
Dorling JS, Field DJ, Manktelow B (2005) Neonatal disease severity scoring systems. Arch Dis Child Fetal Neonatal Ed 90:F11–16PubMedCrossRef
21.
Kumar D, Super DM, Fajardo RA, Stork EE, Moore JJ, Saker FA (2004) Predicting outcome in neonatal hypoxic respiratory failure with the score for neonatal acute physiology (SNAP) and highest oxygen index (OI) in the first 24 hours of admission. J Perinatol 24:376–381PubMedCrossRef
22.
Chiesa C, Panero A, Rossi N, Stegagno M, De Giusti M, Osborn JF, Pacifico L (1998) Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis 26:664–672PubMedCrossRef
23.
Chiesa C, Pellegrini G, Panero A, Osborn JF, Signore F, Assumma M, Pacifico L (2003) C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clin Chem 49:60–68PubMedCrossRef
24.
Cetinkaya M, Ozkan H, Koksal N, Celebi S, Hacimustafaoglu M (2009) Comparison of serum amyloid A concentrations with those of C-reactive protein and procalcitonin in diagnosis and follow-up of neonatal sepsis in premature infants. J Perinatol 29:225–231PubMedCrossRef
25.
Dollner H, Vatten L, Austgulen R (2001) Early diagnostic markers for neonatal sepsis: comparing C-reactive protein, interleukin-6, soluble tumour necrosis factor receptors and soluble adhesion molecules. J Clin Epidemiol 54:1251–1257PubMedCrossRef
26.
Murphy K, Weiner J (2012) Use of leukocyte counts in evaluation of early onset neonatal sepsis. Pediatr Infect Dis J 31:16–19PubMedCrossRef
27.
Hofer N, Zacharias E, Muller W, Resch B (2012) An update on the use of C-reactive protein in early onset neonatal sepsis: current insights and new tasks. Neonatology 102:25–36PubMedCrossRef
28.
Bhandari V, Wang C, Rinder C, Rinder H (2008) Hematologic profile of sepsis in neonates: neutrophil CD64 as a diagnostic marker. Pediatrics 121:129–134PubMedCrossRef
29.
Santuz P, Soffiati M, Dorizzi RM, Benedetti M, Zaglia F, Biban P (2008) Procalcitonin for the diagnosis of early onset neonatal sepsis: a multilevel probabilistic approach. Clin Biochem 41:1150–1155PubMedCrossRef
30.
Zelenina M, Li Y, Glorieux I, Arnaud C, Cristini C, Decramer S, Aperia A, Casper C (2006) Urinary aquaporin-2 excretion during early human development. Pediatr Nephrol 21:947–952PubMedCrossRef
31.
Li Y, Zelenina M, Plat-Willson G, Marcoux MO, Aperia A, Casper C (2011) Urinary aquaporin-2 excretion during ibuprofen or indomethacin treatment in preterm infants with patent ductus arteriosus. Acta Paediatr 100:59–66PubMedCrossRef
32.
Jetton JG, Askenazi DJ (2012) Update on acute kidney injury in the neonate. Curr Opin Pediatr 24:191–196PubMedCrossRef
33.
Goldstein B, Giroir B, Randolph A (2005) International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 6:2–8PubMedCrossRef
34.
Vouloumanou EK, Plessa E, Karageorgopoulos DE, Mantadakis E, Falagas ME (2011) Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis. Intensive Care Med 37:747–762PubMedCrossRef
35.
Stocker M, Hop WC, van Rossum AM (2010) Neonatal Procalcitonin Intervention Study (NeoPInS): effect of Procalcitonin-guided decision making on duration of antibiotic therapy in suspected neonatal early-onset sepsis: A multi-centre randomized superiority and non-inferiority Intervention Study. BMC Pediatr 10:89PubMedCrossRef
36.
37.
Mishra UK, Jacobs SE, Doyle LW, Garland SM (2006) Newer approaches to the diagnosis of early onset neonatal sepsis. Arch Dis Child Fetal Neonatal Ed 91:F208–212PubMedCrossRef
38.
Polin RA (2012) Management of neonates with suspected or proven early onset bacterial sepsis. Pediatrics 129:1006–1015PubMedCrossRef
39.
Standage SW, Wong HR (2011) Biomarkers for pediatric sepsis and septic shock. Expert Rev Anti Infect Ther 9:71–79PubMedCrossRef
40.
Chiesa C, Natale F, Pascone R, Osborn JF, Pacifico L, Bonci E, De Curtis M (2011) C reactive protein and procalcitonin: reference intervals for preterm and term newborns during the early neonatal period. Clin Chim Acta 412:1053–1059PubMedCrossRef
41.
Hsu CW, Symons JM (2010) Acute kidney injury: can we improve prognosis? Pediatr Nephrol 25:2401–2412PubMedCrossRef
Metadata
Title
Impact of sepsis on the urinary level of interleukin-18 and cystatin C in critically ill neonates
Authors
Yanhong Li
Xiaozhong Li
Xiaofei Zhou
Jie Yan
Xueping Zhu
Jian Pan
Meifang Jin
Xueming Zhu
Xing Feng
Zhihui Xiao
Publication date
01-01-2013
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 1/2013
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-012-2285-7

Other articles of this Issue 1/2013

Pediatric Nephrology 1/2013 Go to the issue

Original Article

Renal phosphate handling in Gitelman syndrome—the results of a case–control study

Erratum

Erratum to: Ambulatory blood pressure status in children: comparing alternate limit sources

Review

Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative

Original Article

Skin autofluorescence as a marker of cardiovascular risk in children with chronic kidney disease

Educational Review

Cystic kidney diseases: many ways to form a cyst

Original Article

Masked hypertension is prevalent in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study